Get the Stockscreener App
3.00
2.39%
0.07
After Hours:
3.00
Zentalis Pharmaceuticals Inc Stock (ZNTL) Forecast
The Zentalis Pharmaceuticals Inc (ZNTL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $34.14, representing a +1,038% increase from the current price of $3.00. The highest analyst price target is $43.17, and the lowest is $25.12.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ZNTL Price Target
Average 44.56
(+1,385% Upside)
Is Zentalis Pharmaceuticals Inc (ZNTL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.59 | Neutral |
| STOCH(9,6) | 11.19 | Buy |
| STOCHRSI(14) | 12.40 | Buy |
| MACD(12,26) | -0.1137 | Sell |
| ADX(14) | 15.25 | Neutral |
| William %R | -82.99 | Buy |
| CCI(14) | -84.14 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.2295
Sell
|
3.145
Sell
|
| MA20 |
3.3498
Sell
|
3.2607
Sell
|
| MA50 |
3.3109
Sell
|
3.3887
Sell
|
| MA100 |
3.3454
Sell
|
4.1001
Sell
|
| MA200 |
6.7133
Sell
|
6.6048
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ZNTL could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on ZNTL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.59 indicates that ZNTL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.19 indicates that ZNTL is oversold. This indicates that ZNTL price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.4 indicates that ZNTL is oversold. This suggests that ZNTL price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -84.14 indicates that ZNTL is still oversold but not to an extreme extent.
Long-term ZNTL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Zentalis Pharmaceuticals Inc financial reports and earnings history, Zentalis Pharmaceuticals Inc (ZNTL) stock could reach $30.47 by 2030, $48.90 by 2040 and $28.48 by 2050. See the projected annual prices until 2050 of the Zentalis Pharmaceuticals Inc stock below:
- Zentalis Pharmaceuticals Inc (ZNTL) is expected to reach an average price of $23.28 in 2035, with a high prediction of $25.77 and a low estimate of $15.36. This indicates an $676.04% rise from the last recorded price of $3.00.
- Zentalis Pharmaceuticals Inc (ZNTL) stock is projected to chart a bullish course in 2040, with an average price target of $39.54, representing an $1,218% surge from its current level. The forecast ranges from a conservative $36.38 to a sky-high $48.90.
- Our analysts predict Zentalis Pharmaceuticals Inc (ZNTL) to jump -63.56% by 2045, soaring from $0.0191 to an average price of $1.0932, potentially reaching $6.8209. While $0.0191 is the low estimate, the potential upside is significant.
- Zentalis Pharmaceuticals Inc (ZNTL) stock is expected to climb by 2050, reaching an average of $22.37, a $645.57% jump from its current level. However, a wide range of estimates exists, with high and low targets of $28.48 and $23.82, respectively, highlighting the market's uncertainty.
Zentalis Pharmaceuticals Inc Stock (ZNTL) Year by Year Forecast
Zentalis Pharmaceuticals Inc Stock (ZNTL) Price Forecast for 2025
Zentalis Pharmaceuticals Inc Stock (ZNTL) is expected to reach an average price of $44.56 in 2025, with a high prediction of $65.22 and a low estimate of $23.90. This indicates an +1,385% rise from the last recorded price of $3.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $39.97 | $25.12 | $43.17 | +1,232% |
| February, 2025 | $40.35 | $36.86 | $50.43 | +1,245% |
| March, 2025 | $38.40 | $36.07 | $47.88 | +1,180% |
| April, 2025 | $27.71 | $24.20 | $40.44 | +823.81% |
| May, 2025 | $33.43 | $23.90 | $40.97 | +1,014% |
| June, 2025 | $27.01 | $26.87 | $38.21 | +800.19% |
| July, 2025 | $48.54 | $28.62 | $52.46 | +1,518% |
| August, 2025 | $45.98 | $40.99 | $50.42 | +1,433% |
| September, 2025 | $39.68 | $37.12 | $47.58 | +1,223% |
| October, 2025 | $43.00 | $35.47 | $45.72 | +1,333% |
| November, 2025 | $58.34 | $38.59 | $58.66 | +1,845% |
| December, 2025 | $56.90 | $50.52 | $65.22 | +1,797% |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Price Forecast for 2026
The predicted value for Zentalis Pharmaceuticals Inc (ZNTL) in 2026 is set at an average of $43.08. Estimates vary from a peak of $77.62 to a trough of $8.5372, indicating an +1,336% surge from the present price of $3.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $68.38 | $53.30 | $71.75 | +2,179% |
| February, 2026 | $68.11 | $64.95 | $77.62 | +2,170% |
| March, 2026 | $61.83 | $60.09 | $72.98 | +1,961% |
| April, 2026 | $58.24 | $52.80 | $76.60 | +1,841% |
| May, 2026 | $43.86 | $38.40 | $56.41 | +1,362% |
| June, 2026 | $40.80 | $37.25 | $46.25 | +1,260% |
| July, 2026 | $37.17 | $31.78 | $43.21 | +1,139% |
| August, 2026 | $13.65 | $13.44 | $43.93 | +355.05% |
| September, 2026 | $16.01 | $8.5372 | $18.90 | +433.58% |
| October, 2026 | $13.47 | $11.42 | $20.57 | +348.94% |
| November, 2026 | $21.20 | $13.56 | $23.70 | +606.63% |
| December, 2026 | $20.09 | $17.53 | $23.92 | +569.83% |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Zentalis Pharmaceuticals Inc (ZNTL) is $16.12, with a high forecast of $24.23 and a low forecast of $8.0162. This indicates an +437.41% increase from the last price of $3.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $19.14 | $15.85 | $21.36 | +537.85% |
| February, 2027 | $13.45 | $11.70 | $23.23 | +348.21% |
| March, 2027 | $17.00 | $12.81 | $17.57 | +466.74% |
| April, 2027 | $13.64 | $9.3326 | $18.09 | +354.76% |
| May, 2027 | $11.92 | $11.09 | $14.56 | +297.46% |
| June, 2027 | $15.99 | $9.9888 | $17.89 | +432.99% |
| July, 2027 | $12.89 | $11.90 | $17.37 | +329.68% |
| August, 2027 | $11.94 | $10.72 | $12.99 | +298.03% |
| September, 2027 | $10.54 | $8.0162 | $12.11 | +251.23% |
| October, 2027 | $14.96 | $9.7821 | $15.37 | +398.59% |
| November, 2027 | $18.81 | $13.64 | $24.23 | +526.94% |
| December, 2027 | $21.10 | $15.91 | $23.40 | +603.48% |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Price Forecast for 2028
In 2028, Zentalis Pharmaceuticals Inc (ZNTL) is projected to reach an average price of $11.45, with a high projection of $22.13 and a low estimate of $0.78. This indicates an +281.76% rise from the last price of $3.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $19.73 | $18.02 | $21.96 | +557.83% |
| February, 2028 | $18.81 | $16.94 | $22.13 | +526.86% |
| March, 2028 | $16.63 | $16.34 | $20.68 | +454.39% |
| April, 2028 | $12.26 | $11.64 | $16.77 | +308.74% |
| May, 2028 | $3.2882 | $3.0082 | $12.49 | +9.61% |
| June, 2028 | $4.8889 | $3.0534 | $5.9934 | +62.96% |
| July, 2028 | $8.7997 | $4.7241 | $10.18 | +193.32% |
| August, 2028 | $5.6256 | $5.5656 | $10.53 | +87.52% |
| September, 2028 | $7.5163 | $4.4211 | $8.5013 | +150.54% |
| October, 2028 | $8.297 | $7.3016 | $11.97 | +176.57% |
| November, 2028 | $7.0629 | $6.4029 | $10.32 | +135.43% |
| December, 2028 | $0.58 | $0.78 | $7.5881 | -80.67% |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Price Forecast for 2029
The 2029 price forecast for Zentalis Pharmaceuticals Inc Stock (ZNTL) is $19.85 on average, with a high prediction of $39.57 and a low estimate of $0.1289. This represents an +561.73% increase from the previous price of $3.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.7618 | $0.1289 | $13.85 | +158.73% |
| February, 2029 | $28.89 | $4.5332 | $29.10 | +863.11% |
| March, 2029 | $24.72 | $17.77 | $36.19 | +724.16% |
| April, 2029 | $18.21 | $14.48 | $26.39 | +506.87% |
| May, 2029 | $10.81 | $8.3876 | $22.04 | +260.26% |
| June, 2029 | $6.6294 | $2.9394 | $12.93 | +120.98% |
| July, 2029 | $9.6608 | $4.3301 | $12.52 | +222.03% |
| August, 2029 | $19.36 | $9.8112 | $21.22 | +545.42% |
| September, 2029 | $29.15 | $14.60 | $32.23 | +871.80% |
| October, 2029 | $30.38 | $27.54 | $39.57 | +912.53% |
| November, 2029 | $17.01 | $16.71 | $33.07 | +466.91% |
| December, 2029 | $20.88 | $13.32 | $22.64 | +595.96% |
Zentalis Pharmaceuticals Inc Stock (ZNTL) Price Forecast for 2030
Zentalis Pharmaceuticals Inc Stock (ZNTL) is expected to reach an average price of $42.25 in 2030, with a high forecast of $68.04 and a low forecast of $16.46. This signifies an +1,308% surge from the last price of $3.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.48 | $17.09 | $30.47 | +649.35% |
| February, 2030 | $38.43 | $16.46 | $39.29 | +1,181% |
| March, 2030 | $37.52 | $32.34 | $42.13 | +1,151% |
| April, 2030 | $29.84 | $29.22 | $37.42 | +894.83% |
| May, 2030 | $27.31 | $25.42 | $34.73 | +810.22% |
| June, 2030 | $32.75 | $26.12 | $35.75 | +991.60% |
| July, 2030 | $50.10 | $30.66 | $52.24 | +1,570% |
| August, 2030 | $47.78 | $40.79 | $55.44 | +1,493% |
| September, 2030 | $61.08 | $45.74 | $62.15 | +1,936% |
| October, 2030 | $63.10 | $50.59 | $68.04 | +2,003% |
| November, 2030 | $65.22 | $47.75 | $65.81 | +2,074% |
| December, 2030 | $37.47 | $37.09 | $67.26 | +1,149% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):